Cvs Spf 8 | Octinoxate, Oxybenzone Lotion while Breastfeeding
For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Cvs Spf 8 | Octinoxate, Oxybenzone Lotion and its risk associated with lactation. We will also discuss the usage of Cvs Spf 8 | Octinoxate, Oxybenzone Lotion and some common side effects associated with Cvs Spf 8 | Octinoxate, Oxybenzone Lotion.

What is Cvs Spf 8 | Octinoxate, Oxybenzone Lotion used for?


helps prevent sunburn higher SPF gives more sunburn protection retains SPF after 80 minutes of activity in water

Brief: Sunscreen

What are the risk associated with Cvs Spf 8 | Octinoxate, Oxybenzone Lotion usage while breastfeeding? What precautions shall I take while using it in breastfeeding?

Cvs Spf 8 | Octinoxate, Oxybenzone Lotion dangerous while breastfeeding
Our analysis of Octinoxate, Oxybenzone which are active ingredients in Cvs Spf 8 | Octinoxate, Oxybenzone Lotion indicates that Cvs Spf 8 | Octinoxate, Oxybenzone Lotion is dangerous to use in breastfeeding. We strongly recommend you to go through detailed analysis of Octinoxate, Oxybenzone as below and do not use Cvs Spf 8 | Octinoxate, Oxybenzone Lotion during breastfeeding.

Octinoxate and Breastfeeding

Unsafe

Is Cvs Spf 8 | Octinoxate, Oxybenzone Lotion safe while breastfeeding

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500–1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Oxybenzone and Breastfeeding

Dangerous

Oxybenzone has been found in mother’s milk. And has relatively high 1% to 9% skin penetration in lab studies. Oxybenzone has relatively high rates of skin allergy, it has weak estrogen like effects, and its observed as moderate anti-androgen. Oxybenzone is associated with altered birth weight in human studies. It is not recommended to use Oxybenzone during breast feeding.

Note: Study and data for tropical use only.

Warning: Tropical usage in breast area shall be avoided to prevent the Oxybenzone passing orally in Infants.


What should I do if I am breastfeeding mother and I am already exposed to Cvs Spf 8 | Octinoxate, Oxybenzone Lotion?

You should immediately inform your health care provider about Cvs Spf 8 | Octinoxate, Oxybenzone Lotion usage and your breastfeeding interval after usage of . If you feel baby is having abnormal behavior or any other health issue please call 911 immediately or contact nearest medical emergency center.


My health care provider has asked me to use Cvs Spf 8 | Octinoxate, Oxybenzone Lotion, what to do?

Please double check with your doctor if he is aware of your breastfeeding stratus, Ask your doctor if there is any safe alternative of Cvs Spf 8 | Octinoxate, Oxybenzone Lotion. Check with your doctor if you shall temporally stop breastfeeding. You may go for second opinion as well. Still after all of this if your doctor still recommends Cvs Spf 8 | Octinoxate, Oxybenzone Lotion then go for it as they have access on more detailed medical and scientific information and they understand your individual medical situation much better.


If I am using Cvs Spf 8 | Octinoxate, Oxybenzone Lotion, will my baby need extra monitoring?

Extreme level of monitoring required as Cvs Spf 8 | Octinoxate, Oxybenzone Lotion could be dangerous for kid.


Who can I talk to if I have questions about usage of Cvs Spf 8 | Octinoxate, Oxybenzone Lotion in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week